Open AccessIs COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
Author(s) -
Hoepner Robert,
Kamm Christian P,
Friedli Christoph,
Salmen Anke,
Chan Andrew
Publication year - 2022
Publication title -
cns neuroscience and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 69
eISSN - 1755-5949
pISSN - 1755-5930
DOI - 10.1111/cns.13841
Subject(s) - medicine , expanded disability status scale , neuromyelitis optica , spectrum disorder , cd20 , cd8 , multiple sclerosis , immunology , pediatrics , gastroenterology , antibody , psychiatry , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom